The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Geospatial immune variability illuminates differential evolution of lung adenocarcinoma
Open accessAbstract
Remarkable progress in molecular analyses has improved our understanding of the evolution of cancer cells toward immune escape1–5. However, the spatial configurations of immune and stromal cells, which may shed light on the evolution of immune escape across tumor geographical locations, remain unaddressed. We integrated multiregion exome and RNA-sequencing (RNA-seq) data with spatial histology mapped by deep learning in 100 patients with non-small cell lung cancer from the TRACERx cohort6. Cancer subclones derived from immune cold regions were more closely related in mutation space, diversifying more recently than subclones from immune hot regions. In TRACERx and in an independent multisample cohort of 970 patients with lung adenocarcinoma, tumors with more than one immune cold region had a higher risk of relapse, independently of tumor size, stage and number of samples per patient. In lung adenocarcinoma, but not lung squamous cell carcinoma, geometrical irregularity and complexity of the cancer–stromal cell interface significantly increased in tumor regions without disruption of antigen presentation. Decreased lymphocyte accumulation in adjacent stroma was observed in tumors with low clonal neoantigen burden. Collectively, immune geospatial variability elucidates tumor ecological constraints that may shape the emergence of immune-evading subclones and aggressive clinical phenotypes. Multiregion spatial histology, exome and transcriptome data from patients with non-small cell lung cancer suggest that cancer subclones from immune cold regions diversify later than subclones from immune hot regions
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732
Elements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352
Comprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
McGranahan, N., Furness, A. J. S., Rosenthal, R., Ramskov, S., Lyngaa, R., Saini, S. K., Jamal-Hanjani, M., Wilson, G. A., Birkbak, N. J., Hiley, C. T., et al. (2016) · Science · doi:10.1126/science.aaf1490 · Cited by 3,065
Self-citationDistinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590
Tracking the Evolution of Non–Small-Cell Lung Cancer
Jamal-Hanjani, M., Wilson, G. A., McGranahan, N., Birkbak, N. J., Watkins, T. B. K., Veeriah, S., Shafi, S., Johnson, D. H., Mitter, R., Rosenthal, R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616288 · Cited by 2,349
Self-citationFibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Costa, A., Kieffer, Y., Scholer-Dahirel, A., Pelon, F., Bourachot, B., Cardon, M., Sirven, P., Magagna, I., Fuhrmann, L., Bernard, C., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.011 · Cited by 1,705
Deep profiling of mouse splenic architecture with CODEX multiplexed imaging
Goltsev, Y., Samusik, N., Kennedy-Darling, J., Bhate, S., Hale, M., Vazquez, G., Black, S., & Nolan, G. P. (2018) · Cell · doi:10.1016/j.cell.2018.07.010 · Cited by 1,501
Sirinukunwattana, K., Raza, S. E. A., Tsang, Y.-W., Snead, D. R. J., Cree, I. A., & Rajpoot, N. M. (2016) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2016.2525803 · Cited by 1,224
Self-citationKeren, L., Bosse, M., Marquez, D., Angoshtari, R., Jain, S., Varma, S., Yang, S.-R., Kurian, A., Van Valen, D., West, R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.039 · Cited by 1,183
Research works printed but not linked: 29
- Rosenthal, R. et al. Neoantigen-directed immune escape in lung cancer evolution. Nature 567, 479–485 (2019). · DOI · Paper page
- Morris, L. G. T. & Chan, T. A. Lung cancer evolution: what’s immunity got to do with it? Cancer Cell 35, 711–713 (2019). · doi:10.1016/j.ccell.2019.04.009
- Morris, L. G. T. et al. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival. Oncotarget 7, 10051–10063 (2016). · DOI · Paper page
- Milo, I. et al. The immune system profoundly restricts intratumor genetic heterogeneity. Sci. Immunol. 3, eaat1435 (2018). · DOI
- Jia, Q. et al. Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer. Nat. Commun. 9, 5361 (2018). · DOI · Paper page
- Hendry, S. et al. Assessing tumor-infiltrating lymphocytes in solid tumors. Adv. Anat. Pathol. 24, 311–335 (2017). · DOI · Paper page
- Moore, D. A. et al. In situ growth in early lung adenocarcinoma may represent precursor growth or invasive clone outgrowth—a clinically relevant distinction. Mod. Pathol. 32, 1095–1105 (2019). · DOI
- Whittaker, K. A. & Rynearson, T. A. Evidence for environmental and ecological selection in a microbe with no geographic limits to gene flow. Proc. Natl Acad. Sci. USA 114, 2651–2656 (2017). · DOI
- Shafer, A. B. A. & Wolf, J. B. W. Widespread evidence for incipient ecological speciation: a meta-analysis of isolation-by-ecology. Ecol. Lett. 16, 940–950 (2013). · DOI · Paper page
- Salmon, H. et al. Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J. Clin. Invest. 122, 899–910 (2012). · DOI · Paper page
- Thomas, D. A. & Massagué, J. TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 8, 369–380 (2005). · DOI · Paper page
- Joyce, J. A. & Fearon, D. T. T cell exclusion, immune privilege, and the tumor microenvironment. Science 348, 74–80 (2015). · DOI · Paper page
- Sorokin, L. The impact of the extracellular matrix on inflammation. Nat. Rev. Immunol. 10, 712–723 (2010). · DOI · Paper page
- McGranahan, N. et al. Allele-specific HLA loss and immune escape in lung cancer evolution. Cell 171, 1259–1271 (2017). · DOI · Paper page
- Yuan, Y. Modelling the spatial heterogeneity and molecular correlates of lymphocytic infiltration in triple-negative breast cancer. J. R. Soc. Interface 12, 20141153 (2015). · DOI
- Thomas, A., Liu, S. V., Subramaniam, D. S. & Giaccone, G. Refining the treatment of NSCLC according to histological and molecular subtypes. Nat. Rev. Clin. Oncol. 12, 511–526 (2015). · DOI · Paper page
- Giesen, C. et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat. Methods 11, 417–422 (2014). · DOI · Paper page
- Raza, S. E. A. et al. Micro-net: a unified model for segmentation of various objects in microscopy images. Med. Image Anal. 52, 160–173 (2019). · DOI · Paper page
- Abadi, M. et al. TensorFlow: a system for large-scale machine learning. 12th USENIX Conference on Operating Systems Design and Implementation 265–283 (2016).
- Danaher, P. et al. Gene expression markers of tumor-infiltrating leukocytes. J. Immunother. Cancer 5, 18 (2017). · DOI · Paper page
- Holzinger, A. et al. Monoclonal antibody to thyroid transcription factor-1: production, characterization, and usefulness in tumor diagnosis. Hybridoma 15, 49–53 (1996). · doi:10.1089/hyb.1996.15.49
- Matoso, A. et al. Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors. Appl. Immunohistochem. Mol. Morphol. 18, 142–149 (2010). · doi:10.1097/pai.0b013e3181bdf4e7
- Pelosi, G. et al. ΔNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach. J. Thorac. Oncol. 7, 281–290 (2012). · DOI
- Heindl, A. et al. Relevance of spatial heterogeneity of immune infiltration for predicting risk of recurrence after endocrine therapy of ER+ breast cancer . J. Natl Cancer Inst. 110, 166–175 (2018). · DOI
- Heindl, A. et al. Microenvironmental niche divergence shapes BRCA1-dysregulated ovarian cancer morphological plasticity. Nat. Commun. 9, 3917 (2018). · DOI
- Nawaz, S., Heindl, A., Koelble, K. & Yuan, Y. Beyond immune density: critical role of spatial heterogeneity in estrogen receptor-negative breast cancer. Mod. Pathol. 28, 766–777 (2015). · DOI
- Dubuc, B., Quiniou, J. F., Roques-Carmes, C., Tricot, C. & Zucker, S. W. Evaluating the fractal dimension of profiles. Phys. Rev. A 39, 1500–1512 (1989). · doi:10.1103/physreva.39.1500
- Moisy, F. & Jiménez, J. Geometry and clustering of intense structures in isotropic turbulence. J. Fluid Mech. 513, 111–133 (2004). · doi:10.1017/s0022112004009802
- Francis, K. & Palsson, B. O. Effective intercellular communication distances are determined by the relative time constants for cyto/chemokine secretion and diffusion. Proc. Natl Acad. Sci. USA 94, 12258–12262 (1997). · DOI · Paper page
Cited by
Deep learning in histopathology: the path to the clinic
van der Laak, J., Litjens, G., & Ciompi, F. (2021) · Nature Medicine · doi:10.1038/s41591-021-01343-4 · Cited by 902
Harnessing multimodal data integration to advance precision oncology
Boehm, K. M., Khosravi, P., Vanguri, R., Gao, J., & Shah, S. P. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-021-00408-3 · Cited by 662
Pan-cancer integrative histology-genomic analysis via multimodal deep learning
Chen, R. J., Lu, M. Y., Williamson, D. F. K., Chen, T. Y., Lipkova, J., Noor, Z., Shaban, M., Shady, M., Williams, M., Joo, B., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.07.004 · Cited by 660
Scaling Vision Transformers to Gigapixel Images via Hierarchical Self-Supervised Learning
Chen, R. J., Chen, C., Li, Y., Chen, T. Y., Trister, A. D., Krishnan, R. G., & Mahmood, F. (2022) · 2022 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) · doi:10.1109/cvpr52688.2022.01567 · Cited by 621
Artificial intelligence in histopathology: enhancing cancer research and clinical oncology
Shmatko, A., Ghaffari Laleh, N., Gerstung, M., & Kather, J. N. (2022) · Nature Cancer · doi:10.1038/s43018-022-00436-4 · Cited by 446
Multimodal Co-Attention Transformer for Survival Prediction in Gigapixel Whole Slide Images
Chen, R. J., Lu, M. Y., Weng, W.-H., Chen, T. Y., Williamson, D. F., Manz, T., Shady, M., & Mahmood, F. (2021) · 2021 IEEE/CVF International Conference on Computer Vision (ICCV) · doi:10.1109/iccv48922.2021.00398 · Cited by 398
Overcoming resistance to tumor-targeted and immune-targeted therapies
Aldea, M., Andre, F., Marabelle, A., Dogan, S., Barlesi, F., & Soria, J.-C. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1638 · Cited by 311
Xu, Y., Su, G.-H., Ma, D., Xiao, Y., Shao, Z.-M., & Jiang, Y.-Z. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00729-7 · Cited by 163
“201 Furthermore, predictive models that incorporate the immune cell composition and spatial organization correlate with cancer prognosis, which several groups have proven in colorectal cancer, HCC, and melanoma 202 – 205 (Fig.”
BackgroundChen, R. J., Lu, M. Y., Shaban, M., Chen, C., Chen, T. Y., Williamson, D. F. K., & Mahmood, F. (2021) · Lecture Notes in Computer Science · doi:10.1007/978-3-030-87237-3_33 · Cited by 176
Levy-Jurgenson, A., Tekpli, X., Kristensen, V. N., & Yakhini, Z. (2020) · Scientific Reports · doi:10.1038/s41598-020-75708-z · Cited by 155
Enfield, K. S. S., Colliver, E., Lee, C., Magness, A., Moore, D. A., Sivakumar, M., Grigoriadis, K., Pich, O., Karasaki, T., Hobson, P. S., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1380 · Cited by 151
Self-citationA population-level digital histologic biomarker for enhanced prognosis of invasive breast cancer
Amgad, M., Hodge, J. M., Elsebaie, M. A. T., Bodelon, C., Puvanesarajah, S., Gutman, D. A., Siziopikou, K. P., Goldstein, J. A., Gaudet, M. M., Teras, L. R., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02643-7 · Cited by 137
(2021) · doi:10.1038/s43018-021-00190-z · Cited by 92
Wang, X., Barrera, C., Bera, K., Viswanathan, V. S., Azarianpour-Esfahani, S., Koyuncu, C., Velu, P., Feldman, M. D., Yang, M., Fu, P., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn3966 · Cited by 89
Multi-modality artificial intelligence in digital pathology
Qiao, Y., Zhao, L., Luo, C., Luo, Y., Wu, Y., Li, S., Bu, D., & Zhao, Y. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac367 · Cited by 44
Radiology and multi-scale data integration for precision oncology
Paverd, H., Zormpas-Petridis, K., Clayton, H., Burge, S., & Crispin-Ortuzar, M. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00656-0 · Cited by 41
Metadata
- Authors
- TRACERx Consortium, AbdulJabbar, K., Raza, S. E. A., Rosenthal, R., Jamal-Hanjani, M., Veeriah, S., Akarca, A., Lund, T., Moore, D. A., Salgado, R., Al Bakir, M., Zapata, L., Hiley, C. T., Officer, L., Sereno, M., Smith, C. R., Loi, S., Hackshaw, A., Marafioti, T., Quezada, S. A., McGranahan, N., Le Quesne, J., Swanton, C., & Yuan, Y.
- Venue
- Nature Medicine
- Published
- 2020-05-27
- Volume
- 26
- Issue
- 7
- Pages
- 1054-1062
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W3031256816
- Cited by
- 286
- References
- 10
- FWCI
- 13.09
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.